Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
- PMID: 16033647
- PMCID: PMC1215496
- DOI: 10.1186/1475-2840-4-11
Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines
Abstract
Background: The objective of this study was to determine the rate of blood pressure control according to 4 sets of Canadian guidelines published over a decade in patients with diabetes mellitus attending Diabetes Centres in the province of Nova Scotia.
Methods: One hundred randomly selected charts from each of 13 Diabetes Centres audited between 1997 and 2001 were extracted from the Diabetes Care Program of Nova Scotia Registry. Multivariate logistic regression analyses examined the relationship between individual characteristics and self-reported antihypertensive use. Included were 1132 adults, mean age 63 years (48% male), with 9 years mean time since diagnosis of diabetes.
Results: According to the 1992 guidelines, 63% of the patients and according to the 2003 guidelines, 84% of patients were above target blood pressure or receiving antihypertensive medications. Forty-seven percent of patients are considered to be hypertensive and not on treatment according to 2003 guidelines. The results of the multivariate analyses showed that the only factors independently associated with anti-hypertensive use was oral anti-hyperglycemic use.
Conclusion: Hypertension is an additional risk factor in those with diabetes mellitus for macrovascular and microvascular complications. The health and budgetary impacts of addressing the treatment gap need to be further explored.
Figures
Similar articles
-
Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009.Cardiovasc Diabetol. 2012 May 18;11:54. doi: 10.1186/1475-2840-11-54. Cardiovasc Diabetol. 2012. PMID: 22607105 Free PMC article.
-
Treatment gaps for hypertension management in rural Canadian patients with type 2 diabetes mellitus.Clin Ther. 2004 Apr;26(4):598-606. doi: 10.1016/s0149-2918(04)90062-8. Clin Ther. 2004. PMID: 15189757
-
For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.Pharmacoepidemiol Drug Saf. 2008 May;17(5):485-94. doi: 10.1002/pds.1589. Pharmacoepidemiol Drug Saf. 2008. PMID: 18383562
-
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2. Can J Cardiol. 2010. PMID: 20485689 Free PMC article. Review.
-
Diabetes Care Program of Nova Scotia: Celebrating 25 Years of Improving Diabetes Care in Nova Scotia.Can J Diabetes. 2018 Jun;42(3):317-324. doi: 10.1016/j.jcjd.2017.06.005. Epub 2017 Aug 16. Can J Diabetes. 2018. PMID: 28822778 Review.
Cited by
-
Doctors' Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice.Int J Hypertens. 2018 Mar 12;2018:8524063. doi: 10.1155/2018/8524063. eCollection 2018. Int J Hypertens. 2018. PMID: 29721335 Free PMC article.
References
-
- Johansen OE, Birkeland KI. Preventing Macrovascular Disease in patient with Type 2 Diabetes Mellitus. Am J Cardiovasc Drugs. 2003;3:283–297. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous